PortfoliosLab logoPortfoliosLab logo
OPCH vs. GILD
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

OPCH vs. GILD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Option Care Health, Inc. (OPCH) and Gilead Sciences, Inc. (GILD). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

OPCH vs. GILD - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
OPCH
Option Care Health, Inc.
-15.51%37.33%-31.14%11.96%5.80%81.84%4.83%4.48%22.68%179.81%
GILD
Gilead Sciences, Inc.
14.19%36.59%18.68%-1.99%23.63%29.95%-6.70%7.88%-9.92%2.96%

Fundamentals

Market Cap

OPCH:

$4.26B

GILD:

$174.63B

EPS

OPCH:

$1.28

GILD:

$6.79

PE Ratio

OPCH:

21.10

GILD:

20.54

PEG Ratio

OPCH:

1.16

GILD:

0.05

PS Ratio

OPCH:

0.78

GILD:

5.94

PB Ratio

OPCH:

3.21

GILD:

7.72

Total Revenue (TTM)

OPCH:

$5.65B

GILD:

$29.44B

Gross Profit (TTM)

OPCH:

$1.09B

GILD:

$23.79B

EBITDA (TTM)

OPCH:

$457.06M

GILD:

$12.90B

Returns By Period

In the year-to-date period, OPCH achieves a -15.51% return, which is significantly lower than GILD's 14.19% return. Over the past 10 years, OPCH has outperformed GILD with an annualized return of 12.14%, while GILD has yielded a comparatively lower 7.74% annualized return.


OPCH

1D
-0.30%
1M
-17.07%
YTD
-15.51%
6M
-3.03%
1Y
-22.98%
3Y*
-5.37%
5Y*
8.07%
10Y*
12.14%

GILD

1D
2.22%
1M
-5.90%
YTD
14.19%
6M
27.11%
1Y
27.69%
3Y*
22.97%
5Y*
20.37%
10Y*
7.74%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

OPCH vs. GILD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OPCH
OPCH Risk / Return Rank: 1111
Overall Rank
OPCH Sharpe Ratio Rank: 1111
Sharpe Ratio Rank
OPCH Sortino Ratio Rank: 1313
Sortino Ratio Rank
OPCH Omega Ratio Rank: 1414
Omega Ratio Rank
OPCH Calmar Ratio Rank: 1010
Calmar Ratio Rank
OPCH Martin Ratio Rank: 99
Martin Ratio Rank

GILD
GILD Risk / Return Rank: 7474
Overall Rank
GILD Sharpe Ratio Rank: 7474
Sharpe Ratio Rank
GILD Sortino Ratio Rank: 7070
Sortino Ratio Rank
GILD Omega Ratio Rank: 6565
Omega Ratio Rank
GILD Calmar Ratio Rank: 7878
Calmar Ratio Rank
GILD Martin Ratio Rank: 8080
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

OPCH vs. GILD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Option Care Health, Inc. (OPCH) and Gilead Sciences, Inc. (GILD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


OPCHGILDDifference

Sharpe ratio

Return per unit of total volatility

-0.73

0.96

-1.69

Sortino ratio

Return per unit of downside risk

-0.91

1.55

-2.46

Omega ratio

Gain probability vs. loss probability

0.89

1.18

-0.29

Calmar ratio

Return relative to maximum drawdown

-0.85

2.03

-2.88

Martin ratio

Return relative to average drawdown

-1.55

5.55

-7.10

OPCH vs. GILD - Sharpe Ratio Comparison

The current OPCH Sharpe Ratio is -0.73, which is lower than the GILD Sharpe Ratio of 0.96. The chart below compares the historical Sharpe Ratios of OPCH and GILD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


OPCHGILDDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.73

0.96

-1.69

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.22

0.86

-0.64

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.22

0.30

-0.08

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.03

0.39

-0.42

Correlation

The correlation between OPCH and GILD is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

OPCH vs. GILD - Dividend Comparison

OPCH has not paid dividends to shareholders, while GILD's dividend yield for the trailing twelve months is around 2.29%.


TTM20252024202320222021202020192018201720162015
OPCH
Option Care Health, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
GILD
Gilead Sciences, Inc.
2.29%2.57%3.33%3.70%3.40%3.91%4.67%3.88%3.65%2.90%2.57%1.27%

Drawdowns

OPCH vs. GILD - Drawdown Comparison

The maximum OPCH drawdown since its inception was -95.83%, which is greater than GILD's maximum drawdown of -70.83%. Use the drawdown chart below to compare losses from any high point for OPCH and GILD.


Loading graphics...

Drawdown Indicators


OPCHGILDDifference

Max Drawdown

Largest peak-to-trough decline

-95.83%

-70.83%

-25.00%

Max Drawdown (1Y)

Largest decline over 1 year

-26.43%

-13.77%

-12.66%

Max Drawdown (5Y)

Largest decline over 5 years

-38.67%

-26.59%

-12.08%

Max Drawdown (10Y)

Largest decline over 10 years

-69.37%

-36.01%

-33.36%

Current Drawdown

Current decline from peak

-70.09%

-10.04%

-60.05%

Average Drawdown

Average peak-to-trough decline

-72.13%

-22.20%

-49.93%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.54%

5.04%

+9.50%

Volatility

OPCH vs. GILD - Volatility Comparison

The current volatility for Option Care Health, Inc. (OPCH) is 5.38%, while Gilead Sciences, Inc. (GILD) has a volatility of 6.41%. This indicates that OPCH experiences smaller price fluctuations and is considered to be less risky than GILD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


OPCHGILDDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.38%

6.41%

-1.03%

Volatility (6M)

Calculated over the trailing 6-month period

22.73%

18.97%

+3.76%

Volatility (1Y)

Calculated over the trailing 1-year period

31.46%

29.00%

+2.46%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

37.33%

23.93%

+13.40%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

55.67%

25.63%

+30.04%

Financials

OPCH vs. GILD - Financials Comparison

This section allows you to compare key financial metrics between Option Care Health, Inc. and Gilead Sciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
1.47B
7.93B
(OPCH) Total Revenue
(GILD) Total Revenue
Values in USD except per share items

OPCH vs. GILD - Profitability Comparison

The chart below illustrates the profitability comparison between Option Care Health, Inc. and Gilead Sciences, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
19.3%
86.8%
Portfolio components
OPCH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Option Care Health, Inc. reported a gross profit of 282.90M and revenue of 1.47B. Therefore, the gross margin over that period was 19.3%.

GILD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Gilead Sciences, Inc. reported a gross profit of 6.88B and revenue of 7.93B. Therefore, the gross margin over that period was 86.8%.

OPCH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Option Care Health, Inc. reported an operating income of 91.50M and revenue of 1.47B, resulting in an operating margin of 6.2%.

GILD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Gilead Sciences, Inc. reported an operating income of 2.96B and revenue of 7.93B, resulting in an operating margin of 37.4%.

OPCH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Option Care Health, Inc. reported a net income of 58.50M and revenue of 1.47B, resulting in a net margin of 4.0%.

GILD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Gilead Sciences, Inc. reported a net income of 2.18B and revenue of 7.93B, resulting in a net margin of 27.6%.